Kelly R. Genga

St. Paul's Hospital
Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Correction: Plasma apolipoprotein A-I is a causal protective factor in sepsis.

Correction: Plasma apolipoprotein A-I is a causal protective factor in sepsis.

Journal: Scientific reports
Published: February 17, 2026

Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: A Phase 3 Randomized Clinical Trial.

Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: A Phase 3 Randomized Clinical Trial.

Journal: JAMA internal medicine
Published: September 08, 2025

Associations between vasomotor symptoms, sleep disturbances, and frequent mood changes individually and within symptom groups across the menopausal transition and early postmenopause: observations from the Study of Women's Health Across the Nation.

Associations between vasomotor symptoms, sleep disturbances, and frequent mood changes individually and within symptom groups across the menopausal transition and early postmenopause: observations from the Study of Women's Health Across the Nation.

Journal: Menopause (New York, N.Y.)
Published: July 24, 2025

The burden of sleep disturbances on quality of life and mental well-being in nearly 50,000 perimenopausal and postmenopausal women with and without concurrent vasomotor symptoms from the United States and Europe.

The burden of sleep disturbances on quality of life and mental well-being in nearly 50,000 perimenopausal and postmenopausal women with and without concurrent vasomotor symptoms from the United States and Europe.

Journal: Menopause (New York, N.Y.)
Published: April 08, 2025

Plasma apolipoprotein A-I is a causal protective factor in sepsis.

Plasma apolipoprotein A-I is a causal protective factor in sepsis.

Journal: Scientific reports
Published: July 09, 2024

Plasma apolipoprotein A-I is a causal protective factor in sepsis.

Plasma apolipoprotein A-I is a causal protective factor in sepsis.

Journal: Scientific reports
Published: July 09, 2024

Modulation of vascular endothelial inflammatory response by proprotein convertase subtilisin-kexin type 9.

Modulation of vascular endothelial inflammatory response by proprotein convertase subtilisin-kexin type 9.

Journal: Atherosclerosis
Published: April 12, 2022

Very Low Density Lipoprotein Receptor Sequesters Lipopolysaccharide Into Adipose Tissue During Sepsis.

Very Low Density Lipoprotein Receptor Sequesters Lipopolysaccharide Into Adipose Tissue During Sepsis.

Journal: Critical care medicine
Published: October 26, 2019

Once or Twice Daily Screening for Weaning the Critically Ill-Have We Set Our Sights Too Low?

Once or Twice Daily Screening for Weaning the Critically Ill-Have We Set Our Sights Too Low?

Journal: Critical care medicine
Published: May 17, 2019

Reduced Proprotein convertase subtilisin/kexin 9 (PCSK9) function increases lipoteichoic acid clearance and improves outcomes in Gram positive septic shock patients.

Reduced Proprotein convertase subtilisin/kexin 9 (PCSK9) function increases lipoteichoic acid clearance and improves outcomes in Gram positive septic shock patients.

Journal: Scientific reports
Published: February 13, 2019

Cholesteryl Ester Transfer Protein Influences High-Density Lipoprotein Levels and Survival in Sepsis.

Cholesteryl Ester Transfer Protein Influences High-Density Lipoprotein Levels and Survival in Sepsis.

Journal: American journal of respiratory and critical care medicine
Published: October 16, 2018

Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors.

Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors.

Journal: EBioMedicine
Published: August 28, 2018
Showing 1-12 of 20

Last Updated: 09/26/2026